FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE and MALAISE
3,509 reports of this reaction
2.2% of all FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE reports
#8 most reported adverse reaction
Overview
MALAISE is the #8 most commonly reported adverse reaction for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, manufactured by GlaxoSmithKline LLC. There are 3,509 FDA adverse event reports linking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE to MALAISE. This represents approximately 2.2% of all 162,228 adverse event reports for this drug.
Patients taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE3,509 of 162,228 reports
MALAISE is a less commonly reported adverse event for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, but still significant enough to appear in the safety profile.
Other Side Effects of FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
In addition to malaise, the following adverse reactions have been reported for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE:
Does FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE cause MALAISE?
MALAISE has been reported as an adverse event in 3,509 FDA reports for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE?
MALAISE accounts for approximately 2.2% of all adverse event reports for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, making it a notable side effect.
What should I do if I experience MALAISE while taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE?
If you experience malaise while taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.